_2020091018165303jzv.jpg "Decoding The World Of ETF")
Sep 17, 2020 05:51 PM IST Moderna's vaccine candidate - mRNA-1273 - is nearing the finish line in its push to enroll 30,000 individuals in a late-stage trial of a novel coronavirus va.
Sep 17, 2020 03:37 PM IST Supply deals have already been agreed for 5.303 billion doses, of which 2.728 billion (51 percent) have been bought by developed countries including the UK, US, Australia, Hong Kong & Macau, Japan, Switzerland and Israel, as well as the European Union
Sep 06, 2020 02:15 PM IST The companies would pledge to adhere to high scientific and ethical standards in the conduct of clinical studies and in their manufacturing processes, the Journal report said, citing the draft of a joint statement that is still being finalized.
Sep 05, 2020 02:30 PM IST The drug developer aims to recruit 30,000 healthy volunteers and said it expected enrollment in the late-stage study, which began in late-July, to be completed in September.
Aug 26, 2020 11:00 PM IST Significantly, the volunteers also produced higher levels of antibodies than those produced by patients who have recovered from COVID-19.
Aug 24, 2020 07:30 PM IST The potential agreement provides for an option for member states to buy an additional 80 million doses for a total of up to 160 million doses, the company said.
Jul 29, 2020 09:54 AM IST Moderna’s proposed price for the COVID-19 vaccine would apply to the United States and other high-income countries, according to a news report.
Jul 27, 2020 10:15 PM IST The trial is the first such late-stage study under the Trump administration's program to speed development of measures against the novel coronavirus, adding to hope that an effective vaccine will help end the pandemic.
Jul 25, 2020 07:57 PM IST With over 1.5 crore people across the globe having contracted the infection, the world is eagerly awaiting a vaccine that would bolster the global fight against COVID-19.
Jul 17, 2020 09:48 PM IST In the case of SARS-CoV-2, there is a spike protein, or the S-protein, which is the flag that the immune system needs to recognize as the signature of the virus.
Jul 17, 2020 06:21 PM IST The talks follow a deal reached in June by four EU states with AstraZeneca for the upfront purchase of 400 million doses of its potential COVID-19 vaccine, in principle available to all 27 EU nations.
Jul 07, 2020 04:55 PM IST Some of the disagreements have stoked concerns over the young biotech firm's relative inexperience and what the sources described as its lack of staff and expertise to oversee the most critical phase of human trials.
Jun 26, 2020 07:35 PM IST Soumya Swaminathan said that Moderna's COVID-19 vaccine candidate was ‘not far behind’ Astrazeneca's, among more than 200 candidates, 15 of which have entered clinical trials
May 28, 2020 02:07 PM IST Moderna said last week that the vaccine candidate, the first to be tested in the United States, produced protective antibodies in a small group of healthy volunteers, offering a glimmer of hope for a vaccine among the most advanced in development.
May 22, 2020 12:50 PM IST In this edition of the Moneycontrol's Explained series, find out if the vaccine is worth the hype.
May 18, 2020 10:27 PM IST Overall, the study showed the vaccine was safe and all study participants produced antibodies against the virus.
May 18, 2020 07:04 PM IST Eight patients who were administered Moderna's vaccine were found to have antibody levels similar to those in blood samples of people who have recovered from COVID-19, according to early results from the study conducted by the National Institutes of Health.
Dec 07, 2018 09:44 AM IST Moderna had originally planned to sell 21.7 million shares for between $22 and $24 per share.
